PharmaVoice

JUNE 23, 2025

In general, the megablockbuster trend is skewing toward drugs that reach a wider range of patients, such as checkpoint inhibitors like Keytruda and GLP-1 weight loss and diabetes medications. Combined, Lilly’s Mounjaro, for diabetes, and Zepbound, for obesity, raked in $16.5 billion last year. Here’s how drugmakers are getting there.

Diabetes 147

Diabetes Packaging Biosimilars 147

STAT

NOVEMBER 3, 2023

The  package crafted by U.S. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July. Senate Finance chair Ron Wyden (D-Ore.)

Packaging 249

Packaging Diabetes 249

STAT

JUNE 24, 2024

It is unclear how the bills could be limited to decrease their cost, and whether pared-down proposals could achieve the bipartisan support needed for inclusion in a health care package expected at the end of the year.

Diabetes 276

Diabetes Packaging 276

STAT

OCTOBER 5, 2023

If a package coalesces, it likely would not be introduced until next year. Patent Office tribunal agreed to review the validity of a Novo Nordisk patent related to its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy at the request of generic drug maker Mylan Pharmaceuticals , Reuters notes.

Dosage 266

Dosage Packaging Diabetes Hospitals 266

pharmaphorum

AUGUST 11, 2020

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. Collaborating to prevent diabetes. We’ve got two such projects in the UK, in Leicester and Manchester,” says Sahota. “We

Diabetes 111

Diabetes Packaging Communication 111

Pharma Pathway

DECEMBER 3, 2022

Torrent Pharmaceutical Limited- Walk-Ins for M.Pharm/ M.Sc/ B.Pharm/ B.Sc/ ITI in QA/ QC/ Tablet/ Packaging Departments On 4th Dec’ 2022. Torrent Pharma enjoys dominance in the niche therapeutic areas like, cardiovascular and central nervous system, gastro-intestinal, pain management and oral anti-diabetic segments.

Packaging 77

Packaging Diabetes Hospitals 77

Express Pharma

JUNE 26, 2025

In a recent move, Kashmik launched Dapagliflozin under the DAPNEC brand in the anti-diabetic segment. The company is also investing ₹4–5 crore in automating its packaging operations. The product is priced up to 400 per cent lower than comparable brands in the market.

59

59

European Pharmaceutical Review

DECEMBER 15, 2022

At least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), mainly Africa, are set to benefit from Eli Lilly and Company and manufacturer EVA Pharmaceutical’s new collaboration delivering a sustainable supply of high-quality, affordable human and analogue insulin to this population.

Diabetes 97

Diabetes Packaging Communication 97

pharmaphorum

JANUARY 24, 2023

Eli Lilly is leaving nothing to chance when it comes to making the most of its fast-growing diabetes therapy Mounjaro – it is investing another $450 million at a facility in North Carolina that will make the drug. It will boost the site’s its capacity for parenteral filling, device assembly and packaging even further.

Diabetes 97

Diabetes Packaging 97

European Pharmaceutical Review

NOVEMBER 10, 2023

According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging. Once equipped, the facility is expected to create a total of 800 jobs: 700 jobs in the new API facility and 100 jobs in the new packaging facility.

Packaging 111

Packaging Pharmaceutical Manufacturing Diabetes 111

Express Pharma

MARCH 11, 2025

Empagliflozin is a Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitor used in the treatment of type-2 diabetes mellitus, chronic kidney disease (CKD), and chronic heart failure (HF). Alkem has introduced an anti-counterfeit security band on the packaging of Empanorm.

Diabetes 59

Diabetes Packaging 59

Pharmaceutical Technology

JULY 15, 2022

The bill still must pass the Senate, and moreover, how uninsured people with diabetes will deal with steep prices still remains a question. CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). In-house manufacturing the norm.

Biosimilars 131

Biosimilars Diabetes Documentation Packaging 131

Flip the Pharmacy

JULY 22, 2024

The Prescription Shop filled a large portion of scripts for hospice and was very involved with the enhanced services of CPESN, including electronic care (eCare) plans, adherence packaging and comprehensive medication reviews (CMR). They are focused on bridging the gap between pharmacy and mental health.

Community Pharmacies 98

Community Pharmacies Sterile Compounds Data Entry Independent Pharmacies 98

Pharmafile

JANUARY 25, 2023

Lilly’s expansion is set to include the addition of further parenteral filling, device assembly and packaging capacity in order to meet the growing demand for the company’s incretin-based diabetes treatments and medications. read more

Packaging 52

Packaging Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

MARCH 16, 2025

and Europe held manufacturers accountable for their environmental impact, leading to an increase in partnerships with tech companies focused on sustainable packaging and production solutions. Regulatory bodies in the U.S. Finally, reshoring and localised production emerged as key strategies for improving supply chain resilience.

Biosimilars 110

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 110

Pharmaceutical Technology

JUNE 12, 2025

The drugmaker’s flagship drug semaglutide, known under the brand names Wegovy and Ozempic for obesity and type 2 diabetes treatment respectively, targets the glucagon-like peptide-1 receptor (GLP-1R), a key component of the incretin system. Give your business an edge with our leading industry insights.

Diabetes 59

Diabetes Compounding Communication Hospitals 59

NY Times

DECEMBER 6, 2021

President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.

Packaging 59

Packaging Diabetes 59

pharmaphorum

JUNE 18, 2021

UK company MIOTIFY has developed a web-based software platform that product teams can use to configure medical algorithms quickly, create code packages to harness them and generate supporting documentation – all in a format that is designed to meet regulatory requirements for software as a medical device (SaMD). Sheena Macpherson.

Documentation 98

Documentation Packaging Diabetes 98

Flip the Pharmacy

JULY 30, 2024

Atlantis Pharmacy showed me the opportunity of offering adherence packaging, electronic care (eCare) planning, international normalized ration (INR) testing and monitoring, and medication synchronization (MedSync) to patients.

Health and Personal Care Stores 98

Health and Personal Care Stores Sterile Compounds Independent Pharmacies Community Pharmacies 98

Pharmaceutical Technology

JUNE 6, 2025

Find out more RTU cartridges are essential for storing glucagon-like peptide-1 drugs, biologics, insulin and hormone therapies used for treating diabetes, obesity and other immunological conditions. It will further extend the site’s manufacturing capabilities for high-value solutions.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes Hospitals 52

The Happy PharmD

JUNE 27, 2022

The fallout of burnout, such as cardiovascular diseases, diabetes, hospitalizations, divorce, and suicide, reveals that it is an important subject that should be paid the necessary attention it deserves. The special care package can be accessed here. . Conclusion.

Packaging 52

Packaging Pharmacy Management Diabetes Hospitals 52

RX Note

DECEMBER 25, 2024

meats, fruits and vegetables) rather than their packaged counterparts. Almost all national and international organizations recommend dietary sodium reduction as part of the nonpharmacologic therapy for hypertension. In 2013, the WHO recommends that adults consume <2000 mg/day of sodium. breakfast cereals, canned or frozen foods).

Community Pharmacies 40

Community Pharmacies Packaging Labelling Diabetes 40

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. Diabetes Therapy. the enteric coating and the capsule dissolve.

Biosimilars 105

Biosimilars Diabetes Immunization Immunity 105

RX Note

JUNE 5, 2023

No Added Sugar: No sugar or ingredient containing sugar was added during processing or packaging. The systematic review found no evidence of long-term benefit on measures of body fatness in adults or children, and potential undesirable effects from long-term use in the form of increased risk of type 2 diabetes, CVDs and mortality in adults.

Packaging 52

Packaging Compounding Diabetes 52

Pharmaceutical Technology

JUNE 18, 2025

The full UK test will also look at a person’s susceptibility to developing type 2 diabetes, prostate cancer and breast cancer. The test was also evaluated in a clinical trial conducted with the NHS to evaluate its ability to detect signs of cardiovascular disease. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Diabetes 52

Pharmaceutical Technology

JUNE 18, 2025

Find out more Fleischer said that the programme will provide more services for patients receiving its glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide, which is marketed as Wegovy for weight loss and Ozempic in type 2 diabetes, including fitness and dietary advice. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Compounding 52

pharmaphorum

AUGUST 24, 2020

“We believe that stable small molecule therapy will offer both efficacy and durability advantages to the current treatment paradigm for common retinal diseases such as diabetic retinopathy, DR, and neovascular age related macular degeneration, nAMD”. Ophthalmic Drugs Conference. 23 rd -24 th November 2020. OphthalmicDrugs.

Packaging 52

Packaging Diabetes 52

FADIC

JULY 14, 2024

Proper selection of nonprescription drugs is important for all patients, but it is particularly critical for individuals of advanced age, pregnant/lactating women, individuals with preexisting medical conditions (such as diabetes), the pediatric population, and those currently using prescription drugs.

Adverse Reactions 105

Adverse Reactions Dosage Mayo Clinic Medical Schools 105

Pharmaceutical Technology

JUNE 23, 2025

Eylea is approved in four indications in Europe: the treatment of ‘wet’ age-related macular degeneration (AMD), visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), visual impairment due to diabetic macular oedema (DME) and visual impairment due to myopic choroidal neovascularisation (myopic CNV).

Biosimilars 52

Biosimilars Pharmaceutical Manufacturing Communication Hospitals 52

Fuld & Company Blog

MARCH 27, 2023

The background of semaglutide Nearly 20 years ago the first glucagon-like peptide 1 (GLP-1), a class of Type 2 diabetes drug that improves blood sugar, was launched, creating what is today a market worth nearly $30B. This market was estimated to be worth over $80 billion, in addition to the $30 billion diabetes market.

Diabetes 52

Diabetes Online Pharmacies Packaging Pharmaceutical Companies 52

BioPharma Dive

JUNE 23, 2025

Originally developed in the 1970s to treat diabetes, these drugs—such as Ozempic, Wegovy, and Mounjaro—have become headline-makers for their ability to induce significant weight loss. This shift raises ethical questions around prioritizing supply for diabetes patients versus those seeking treatment for obesity or cosmetic weight loss.

Diabetes 52

Diabetes Drug Pricing Packaging Drug Development 52

Pharma Marketing Network

DECEMBER 4, 2024

For example, a campaign on “Managing Diabetes with XYZ Drug” can position your brand as a helpful resource. Highlight your commitment to eco-friendly practices, from reducing packaging waste to sourcing ethically. Branded Content: Educate, Don’t Just Promote Branded content is an excellent way to educate HCPs and patients.

Communication 52

Communication Packaging Biosimilars Diabetes 52

Pharmaceutical Technology

JANUARY 15, 2023

While Catalent Inc and PCI Pharma Services are in charge of the solid dose and packaging of Lupkynis, Lonza is manufacturing the small molecule API. Vetter Pharma-Fertigung GmbH & Co KG is conducting the parenteral manufacture and packaging for Trulicity.

Labelling 52

Labelling Packaging Communication Diabetes 52

Birth Control Pharmacist

SEPTEMBER 20, 2021

1 Females with prediabetes and diabetes should monitor their blood glucose levels, and females with hypertriglyceridemia should consider a different birth control as this may increase the risk of pancreatitis. Nextstellis (Drospirenone and Estetrol) [package insert]. REFERENCES. Accessed June 25, 2021. Accessed April 2021. .

Adverse Reactions 52

Adverse Reactions Packaging Labelling Diabetes 52

Express Pharma

JUNE 11, 2025

Children living with type 1 diabetes (T1D) can survive and go on to lead long, healthy lives with the right care. As T1D cases continue to rise among CYP, so does the urgency to make lifesaving insulin and other essential diabetes care products available where they are needed most. What does the report find? million globally by 2040.

Diabetes 66

Diabetes Biosimilars Packaging Communication 66

Quality Matters

NOVEMBER 11, 2022

Starting in 2018, concerning levels of these impurities were found in commonly prescribed medicines for blood pressure, diabetes, and other conditions. When they are metabolized, they are converted to alkylating agents that can damage DNA and have been linked to cancer.

Packaging 52

Packaging Documentation Compounding Diabetes 52

PharmaShots

FEBRUARY 27, 2023

Manan Sharma- “as from the technology side I will start with the recently used cases like the government of India has already made it mandatory for around 300 drugs to have their barcode on the packaging to track and trace the information of the drugs. We can order drugs online and can have online consultations.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40